The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior
Open accessAbstract
Symptoms of depression can be induced in humans through blockade of acetylcholinesterase (AChE) whereas antidepressant-like effects can be produced in animal models and some clinical trials by limiting activity of acetylcholine (ACh) receptors. Thus, ACh signaling could contribute to the etiology of mood regulation. To test this hypothesis, we administered the AChE inhibitor physostigmine to mice and demonstrated an increase in anxiety- and depression-like behaviors that was reversed by administration of nicotinic or muscarinic antagonists. The behavioral effects of physostigmine were also reversed by administration of the selective serotonin reuptake inhibitor fluoxetine. Administration of fluoxetine also increased AChE activity throughout the brain, with the greatest change in the hippocampus. To determine whether cholinergic signaling in the hippocampus could contribute to the systemic effects of cholinergic drugs, we infused physostigmine or virally delivered shRNAs targeting AChE into the hippocampus. Both pharmacological and molecular genetic decreases in hippocampal AChE activity increased anxiety- and depression-like behaviors and decreased resilience to repeated stress in a social defeat paradigm. The behavioral changes due to shRNA-mediated knockdown of AChE were rescued by coinfusion of an shRNA-resistant AChE transgene into the hippocampus and reversed by systemic administration of fluoxetine. These data demonstrate that ACh signaling in the hippocampus promotes behaviors related to anxiety and depression. The sensitivity of these effects to fluoxetine suggests that shRNA-mediated knockdown of hippocampal AChE represents a model for anxiety- and depression-like phenotypes. Furthermore, abnormalities in the cholinergic system may be critical for the etiology of mood disorders and could represent an endophenotype of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Increasing acetylcholine signaling in the hippocampus via local knockdown of acetylcholine esterase (AChE) results in increased avoidance of anxiogenic environments, in-creased immobility in response to inescapable stress, and decreased threshold for social defeat (Mineur et al. 2013).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Mineur et al. 2013
In the citing paper
“while increased ACh transmission can increase behaviors related to depression in humans (Risch et al., 1980) and rodents (Mineur et al., 2013), the type of circuits/cell types that are modulated by ACh or nAChRs can have opposite effects on mood regulation, and the outcome on behavior depends on the sum of these effects.”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Mineur et al., 2013
In the citing paper
“These results indicate that abnormal nicotinic signaling may underlie depression symptoms (Mineur et al., 2013; Tizabi et al., 2000)”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Mineur et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES
Karnovsky, M. J., & ROOTS, L. (1964) · Journal of Histochemistry & Cytochemistry · doi:10.1177/12.3.219 · Cited by 3,368
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 1×
“To test whether manipulations of AChE could potentiate an animal’s susceptibility to psychosocial stress induced by repeated defeat, we also used the submaximal defeat paradigm as reported previously (43).”
MethodEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature reviews. Neuroscience · doi:10.1038/35067589 · Cited by 1,437
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404
Self-citationA cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134
Linking Molecules to Mood: New Insight Into the Biology of Depression
Krishnan, V., & Nestler, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.10030434 · Cited by 666
Acute stress facilitates long-lasting changes in cholinergic gene expression
Kaufer, D., Friedman, A., Seidman, S., & Soreq, H. (1998) · Nature · doi:10.1038/30741 · Cited by 588
ΔFosB in brain reward circuits mediates resilience to stress and antidepressant responses
Vialou, V., Robison, A. J., LaPlant, Q. C., Covington, H. E., Dietz, D. M., Ohnishi, Y. N., Mouzon, E., Rush, A. J., Watts, E. L., Wallace, D. L., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2551 · Cited by 479
Nicotine Decreases Food Intake Through Activation of POMC Neurons
Mineur, Y. S., Abizaid, A., Rao, Y., Salas, R., DiLeone, R. J., Gündisch, D., Diano, S., De Biasi, M., Horvath, T. L., Gao, X.-B., et al. (2011) · Science · doi:10.1126/science.1201889 · Cited by 439
Self-citationFurey, M. L., & Drevets, W. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1121 · Cited by 417
Social model of depression in mice of C57BL/6J strain
Kudryavtseva, N. N., Bakshtanovskaya, I. V., & Koryakina, L. A. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90284-9 · Cited by 404
The Flinders sensitive line rats: a genetic animal model of depression
Overstreet, D. H. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80230-1 · Cited by 369 · cited 4×
“pha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned,”
BackgroundResultInfluentialPhasic acetylcholine release and the volume transmission hypothesis: time to move on
Sarter, M. F., Parikh, V., & Howe, W. M. (2009) · Nature reviews. Neuroscience · doi:10.1038/nrn2635 · Cited by 340
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
Mineur, Y. S., & Picciotto, M. R. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.004 · Cited by 285
Self-citationThe Role of the Dorsal Hippocampal Serotonergic and Cholinergic Systems in the Modulation of Anxiety
File, S. E., Kenny, P. J., & Cheeta, S. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00198-2 · Cited by 239
Alternative Splicing and Neuritic mRNA Translocation Under Long-Term Neuronal Hypersensitivity
Meshorer, E., Erb, C., Gazit, R., Pavlovsky, L., Kaufer, D., Friedman, A., Glick, D., Ben‐Arie, N., & Soreq, H. (2002) · Science · doi:10.1126/science.1066752 · Cited by 228
Changes in Brain MicroRNAs Contribute to Cholinergic Stress Reactions
Meerson, A., Cacheaux, L. P., Goosens, K. A., Sapolsky, R. M., Soreq, H., & Kaufer, D. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9252-1 · Cited by 209
Wilkinson, M. B., Dias, C., Magida, J., Mazei-Robison, M., Lobo, M., Kennedy, P., Dietz, D., Covington, H., Russo, S., Neve, R., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0039-11.2011 · Cited by 170
Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior
Warner-Schmidt, J. L., Schmidt, E. F., Marshall, J. J., Rubin, A. J., Arango-Lievano, M., Kaplitt, M. G., Ibañez-Tallon, I., Heintz, N., & Greengard, P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209293109 · Cited by 163 · cited 4×
“pha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned,”
BackgroundInfluentialMark, G. P., Rada, P. V., & Shors, T. J. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00211-4 · Cited by 149
Cholinergic modulation of hippocampal cells and circuits
Cobb, S., & Davies, C. H. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.076539 · Cited by 145
Mineur, Y. S., Somenzi, O., & Picciotto, M. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.01.006 · Cited by 137
Self-citationSternfeld, M., Shoham, S., Klein, O., Flores‐Flores, C., Evron, T., Idelson, G. H., Kitsberg, D., Patrick, J. W., & Soreq, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140004597 · Cited by 130
George, T. P., Sacco, K. A., Vessicchio, J. C., Weinberger, A. H., & Shytle, R. D. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b49e · Cited by 128
Cholinergic Pathways and the Ascending Reticular Activating System of the Human Braina
Mesulam, M. M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17472.x · Cited by 122
Persistent β 2 *-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder
Saricicek, A., Esterlis, I., Maloney, K. H., Mineur, Y. S., Ruf, B. M., Muralidharan, A., Chen, J. I., Cosgrove, K. P., Kerestes, R., Ghose, S., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11101546 · Cited by 118
Self-citationFile, S. E., Gonzalez, L. E., & Andrews, N. (1998) · Behavioral Neuroscience · doi:10.1037//0735-7044.112.2.352 · Cited by 115
Physostigmine induction of depressive symptomatology in normal human subjects
Risch, S. C., Cohen, R. M., Janowsky, D. S., Kalin, N. H., Sitaram, N., Christian Gillin, J., & Murphy, D. L. (1981) · Psychiatry Research · doi:10.1016/0165-1781(81)90012-3 · Cited by 113
Gilad, G. M. (1987) · Psychoneuroendocrinology · doi:10.1016/0306-4530(87)90002-3 · Cited by 94
Kaufer, D., Friedman, A., Seidman, S., & Soreq, H. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00046-0 · Cited by 90
Smythe, J. W., Bhatnagar, S., Murphy, D., Timothy, C., & Costall, B. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00311-0 · Cited by 68
Antisense prevention of neuronal damages following head injury in mice
Shohami, E., Kaufer, D., Chen, Y., Seidman, S., Cohen, O., Ginzberg, D., Melamed‐Book, N., Yirmiya, R., & Soreq, H. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000104 · Cited by 64
Mineur, Y. S., Einstein, E. B., Seymour, P. A., Coe, J. W., O'Neill, B. T., Rollema, H., & Picciotto, M. R. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328347546d · Cited by 49
Self-citationMartinowich, K., Schloesser, R. J., Lu, Y., Jimenez, D. V., Paredes, D., Greene, J. S., Greig, N. H., Manji, H. K., & Lu, B. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.08.014 · Cited by 48
Andr�, J., & Lojda, Z. (1986) · Histochemistry and Cell Biology · doi:10.1007/bf00482994 · Cited by 43
Tucci, S., Cheeta, S., Seth, P., & File, S. E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1403-4 · Cited by 38
Serendipity Strikes Again: Scopolamine as an Antidepressant Agent in Bipolar Depressed Patients
Janowsky, D. S. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0239-6 · Cited by 26
Hasey, G., & Hanin, I. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90041-j · Cited by 22
Salas, R., Main, A., Gangitano, D. A., Zimmerman, G., Ben‐Ari, S., Soreq, H., & Biasi, M. D. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048454 · Cited by 21
Contributions of selective knockout studies to understanding cholinesterase disposition and function
Camp, S., Zhang, L., Krejci, É., Dobbertin, A., Bernard, V., Girard, E., Duysen, E. G., Lockridge, O., Jaco, A. D., & Taylor, P. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.02.008 · Cited by 17
Dilsaver, S., Peck, J., & Overstreet, D. (1992) · Pharmacology, Biochemistry and Behavior · doi:10.1016/0091-3057(92)90053-i · Cited by 14
Hrabovská, A., Duysen, E. G., Sanders, J. D., Murrin, L. C., & Lockridge, O. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.10.014 · Cited by 12
Research works printed but not linked: 1
- 10.1037/0735-7044.112.2.352 · DOI
Cited by
Sorted by citations
Sarasamma, S., Audira, G., Siregar, P., Malhotra, N., Lai, Y., Liang, S., Chen, J., Chen, K. H. ‐., & Hsiao, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041410 · Cited by 477
Patki, G., Solanki, N., Atrooz, F., Allam, F., & Salim, S. (2013) · Brain Research · doi:10.1016/j.brainres.2013.09.033 · Cited by 380
Walczak, Ł. J., & Herbet, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179290 · Cited by 376
Fluorescent probes for the detection of disease-associated biomarkers
Dou, W., Han, H., Sedgwick, A. C., Zhu, G.-B., Zang, Y., Yang, X., Yoon, J., James, T. D., Li, J. X., & He, X. (2022) · 中国科学通报：英文版 · doi:10.1016/j.scib.2022.01.014 · Cited by 267
Wang, X., Li, P., Ding, Q., Wu, C., Zhang, W., & Tang, B. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11414 · Cited by 254
Metadata
- Authors
- Mineur, Y. S., Obayemi, A., Wigestrand, M. B., Fote, G. M., Calarco, C. A., Li, A. M., & Picciotto, M. R.
- Affiliations
- Yale University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-02-11
- Volume
- 110
- Issue
- 9
- Pages
- 3573-3578
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3587265
- OpenAlex
- W2020386906
- Cited by
- 375
- References
- 46
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 21 · 2023: 24 · 2022: 38 · 2021: 34 · 2020: 38 · 2019: 30 · 2018: 33 · 2017: 20 · 2016: 24 · 2015: 27 · 2014: 18 · 2013: 15
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DA033945)
- National Institute of Mental Health (MH077681, R01MH077681)
- National Institute on Drug Abuse (P50DA033945, DA033945)
- National Institute of General Medical Sciences (T32GM007205)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- cholinergic neurotransmission, hippocampus, acetylcholinesterase, physostigmine, anxiety-like behavior, depression-like behavior, social defeat, fluoxetine, nicotinic acetylcholine receptors, muscarinic receptors, shRNA knockdown, mood disorders
- MeSH terms
- Acetylcholinesterase, Dependovirus, Animals, Antidepressive Agents, Anxiety, Behavior, Animal, Depression, Fluoxetine, Hippocampus, Humans, Male, Mice, Inbred C57BL, Phenotype, Physostigmine, Receptors, Cholinergic, Stress, Psychological, Time Factors, Signal Transduction, Cholinergic Antagonists, Hindlimb Suspension, RNA, Small Interfering, Mice, Resilience, Psychological, Gene Knockdown Techniques, Cholinergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
